800 mg ibuprofen/26.6 mg famotidine ( DrugBank: Famotidine, Ibuprofen )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 107 | Juvenile idiopathic arthritis | 1 |
107. Juvenile idiopathic arthritis
Clinical trials : 441 / Drugs : 282 - (DrugBank : 56) / Drug target genes : 52 - Drug target pathways : 142
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01563185 (ClinicalTrials.gov) | April 2012 | 20/3/2012 | Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic Arthritis | A Multicenter, Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic Arthritis | Juvenile Idiopathic Arthritis | Drug: 800 mg ibuprofen/26.6 mg famotidine | Horizon Pharma Ireland, Ltd., Dublin Ireland | Pediatric Rheumatology Collaborative Study Group | Completed | 10 Years | 16 Years | All | 12 | Phase 4 | United States |